methionine has been researched along with fenofibrate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bissonnette, R; Boucher, B; Cohn, JS; Genest, J; Rozen, R; Treacy, E | 1 |
| Cao, Y; Chen, C; Qi, R; Wang, Y; Xu, L; Zhang, Q | 1 |
| Baiyisaiti, A; Cao, YN; Hsu, SH; Qi, R; Wong, CW | 1 |
| Holeček, M; Vodeničarovová, M | 1 |
1 review(s) available for methionine and fenofibrate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for methionine and fenofibrate
| Article | Year |
|---|---|
Fenofibrate raises plasma homocysteine levels in the fasted and fed states.
Topics: Adult; Coronary Artery Disease; Dairy Products; Dietary Fats; Double-Blind Method; Eating; Fasting; Fenofibrate; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Male; Methionine; Middle Aged; Risk Factors | 2001 |
4 other study(ies) available for methionine and fenofibrate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Fenofibrate nanoliposome: Preparation and its inhibitory effects on nonalcoholic fatty liver disease in mice.
Topics: Animals; Choline; Fenofibrate; Hypolipidemic Agents; Liposomes; Liver; Methionine; Mice; Nanoparticles; Non-alcoholic Fatty Liver Disease | 2016 |
Polyurethane Nanoparticle-Loaded Fenofibrate Exerts Inhibitory Effects on Nonalcoholic Fatty Liver Disease in Mice.
Topics: Animals; Drug Carriers; Fenofibrate; Hep G2 Cells; Humans; Hypolipidemic Agents; Liver; Male; Methionine; Mice; Mice, Inbred C57BL; Nanoparticles; Non-alcoholic Fatty Liver Disease; Polyurethanes | 2018 |
Effects of low and high doses of fenofibrate on protein, amino acid, and energy metabolism in rat.
Topics: Amino Acids; Amino Acids, Branched-Chain; Animals; Carnitine; Energy Metabolism; Fenofibrate; Glycine; Hepatomegaly; Humans; Hypolipidemic Agents; Leucine; Liver; Lysine; Male; Methionine; Muscle, Skeletal; Oxidation-Reduction; Proteins; Rats; Rats, Wistar | 2020 |